Newsroom

latest news from ose
and across our portfolio

Featured News

Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Article links to www.globenewswire.com
Sitryx
Sitryx raises additional $39 million to progress development of disease-modifying therapeutics
Article links to prn.to
The Oxford-Harrington Rare Disease Centre Launches
The Oxford-Harrington Rare Disease Centre Launches
Article links to www.beacontx.com
Beacon Therapeutics
Beacon Therapeutics launches with £96 million to develop a new generation of gene therapies for retinal diseases
Article links to innovation.ox.ac.uk
Oxford University retains No. 1 spot for spinouts
Oxford University retains No. 1 spot for spinouts
Article links to www.ultromics.com
Ultromics
Ultromics granted FDA Breakthrough Device Designation
Article links to www.caristo.com
Caristo Diagnostics
Caristo Diagnostics Completes Series A Financing and Welcomes New CEO
Article links to quantummotion.tech
Quantum Motion Technologies
Quantum Motion Raises £42 Million Investment Round

All News

Portfolio NewsUltromicsUltromics announces partnership to expedite development of Echo AI algorithmPortfolio NewsUltromicsCMS publishes final Clinical APC rule for Ultromics EchoGo® Heart FailurePortfolio NewsUltromicsNew Technology Add-On Payment (NTAP) for Ultromics: Advancing HFpEF DiagnosisPortfolio NewsUltromicsStudy Confirms Ultromics’ AI Can Improve HFpEF Detection Using a Single Echocardiogram ViewPortfolio NewsUltromicsUltromics granted FDA Breakthrough Device DesignationPortfolio NewsUltromicsUltromics receives FDA clearance for its breakthrough device EchoGo Heart FailurePortfolio NewsUltromicsUltromics joins FNIH partnership to transform heart failure detectionPortfolio NewsUltromicsUltromics: Wolverhampton NHS cardiologists to use new cloud technology to interpret echocardiogramsPortfolio NewsUltromicsUltromics breakthrough study shows AI is a capable of independently reading stress echocardiogramsPortfolio NewsUltromicsCaption Health and Ultromics partner to put heart disease detection and management tools in more handsPortfolio NewsUltromicsUltromics announces collaboration with Janssen to develop AI for patients with amyloidosis with cardiac involvementPortfolio NewsUltromicsUltromics raises $33 million in Series B funding to help transform cardiac disease treatmentPortfolio NewsUltromicsUltromics: EchoGo predicts cardiac-related COVID-19 mortality revealed in WASE studyPortfolio NewsUltromicsUltromics CE mark's EchoGo CorePortfolio NewsUltromicsUltromics receives FDA clearance for EchoGo Pro; a first-of-kind solution to help diagnose CAD